The Newport Beach-based venture capital firm, founded in 2018, partners with biotechnology, pharmaceutical, medical device, and medtech companies with exceptional growth potential and a commitment to addressing unmet medical needs for global patient targets. As a family office venture arm, Cure Ventures aims to propel novel cures to market by discovering and enabling these firms.